home.social

#renalcell — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #renalcell, aggregated by home.social.

  1. Set a ⏲ to join #TumorBoardTuesday on 03.14.23 at 8pm ET

    Join👨🏻‍⚕️@brian_rini @JVentoMD 👨🏻‍⚕️ as they break down 📰Adjuvant treatment in #RenalCellCarcinoma

    🧬 While we finalize the case, collect FREE #CME (AMA & MOC)

    👉🏽integrityce.com/tbt 👈🏼 #OncTwitter #RenalCell

  2. Set a ⏲ to join #TumorBoardTuesday on 03.14.23 at 8pm ET

    Join👨🏻‍⚕️@brian_rini @JVentoMD 👨🏻‍⚕️ as they break down 📰Adjuvant treatment in #RenalCellCarcinoma

    🧬 While we finalize the case, collect FREE #CME (AMA & MOC)

    👉🏽integrityce.com/tbt 👈🏼 #OncTwitter #RenalCell

  3. 9/#TumorBoardTuesday #OncTwitter #NephTwitter #BonumCE

    #ICYMI 🪡#RenalCell #MedTweetorial🧵
    w @brian_rini @shilpaonc @katy_beckermann

    🦺TKI/IO safety data
    🥽Tox to look 4
    ⛑AE mgmt

    ---
    RT @TumorBoardTues
    1/ #OncTwitter #NephTwitter #TumorBoardTuesday
    #RenalCell #MedTweetorial🧵
    w @brian_rini @shilpaonc @katy_beckermann

    🦺TKI/IO safety data
    🥽Tox to look 4
    ⛑AE mgmt

    🆓#CME @BonumCe🔗bit.ly/3VDaK81
    Support by edu grants from Eisai…
    twitter.com/TumorBoardTues/sta

  4. 9/#TumorBoardTuesday #OncTwitter #NephTwitter #BonumCE

    #ICYMI 🪡#RenalCell #MedTweetorial🧵
    w @brian_rini @shilpaonc @katy_beckermann

    🦺TKI/IO safety data
    🥽Tox to look 4
    ⛑AE mgmt

    ---
    RT @TumorBoardTues
    1/ #OncTwitter #NephTwitter #TumorBoardTuesday
    #RenalCell #MedTweetorial🧵
    w @brian_rini @shilpaonc @katy_beckermann

    🦺TKI/IO safety data
    🥽Tox to look 4
    ⛑AE mgmt

    🆓#CME @BonumCe🔗bit.ly/3VDaK81
    Support by edu grants from Eisai…
    twitter.com/TumorBoardTues/sta

  5. 8/ #TumorBoardTuesday #RenalCell #NephTwitter

    🔴#PostTest Q 4️⃣
    🗳️ Pt treated w/ combo of cabozantinib + nivolumab develops G3 hypertension. Cabo therapy is held & pt receives anti-hypertensive medication & BP recovers to baseline. At what dose can cabozantinib be restarted?

  6. 8/ #TumorBoardTuesday #RenalCell #NephTwitter

    🔴#PostTest Q 4️⃣
    🗳️ Pt treated w/ combo of cabozantinib + nivolumab develops G3 hypertension. Cabo therapy is held & pt receives anti-hypertensive medication & BP recovers to baseline. At what dose can cabozantinib be restarted?

  7. 7/ #TumorBoardTuesday #RenalCell #NephTwitter #MedTwitter #BonumCE
    #CME 🔗bit.ly/3FamQyu

    🔴#PostTest Q3️⃣
    🗳️ Pt treated w/ combo of pembrolizumab and lenvatinib for metastatic RCC develops grade 3 diarrhea. How might you diagnose which drug is causing this toxicity?

  8. 7/ #TumorBoardTuesday #RenalCell #NephTwitter #MedTwitter #BonumCE
    #CME 🔗bit.ly/3FamQyu

    🔴#PostTest Q3️⃣
    🗳️ Pt treated w/ combo of pembrolizumab and lenvatinib for metastatic RCC develops grade 3 diarrhea. How might you diagnose which drug is causing this toxicity?

  9. 6/ #TumorBoardTuesday #OncTwitter #RenalCell #NephTwitter #MedTwitter #BonumCE
    #CME 🔗bit.ly/3FamQyu

    🔴#PostTest Q 2️⃣
    🗳️ Which of the following is NOT a characteristic of immune-mediated toxicities associated with the use of ICIs?

  10. 6/ #TumorBoardTuesday #OncTwitter #RenalCell #NephTwitter #MedTwitter #BonumCE
    #CME 🔗bit.ly/3FamQyu

    🔴#PostTest Q 2️⃣
    🗳️ Which of the following is NOT a characteristic of immune-mediated toxicities associated with the use of ICIs?

  11. 🧗🏽Summit RCC Mts🧗🏽┈┈🏔 TKI/IO safety data & AE mgmt #RenalCell🏔┈┈ w guides @shilpaonc @katy_beckermann @brian_rini ┈┈🔹#CME info 👉 bit.ly/3iLN6aX 👈 @BonumCe ┈┈🔸Support by edu grants from Eisai & @Merck 🔹#TumorBoardTuesday #OncTwitter twitter.com/i/broadcasts/1lDGL

  12. 🧗🏽Summit RCC Mts🧗🏽┈┈🏔 TKI/IO safety data & AE mgmt #RenalCell🏔┈┈ w guides @shilpaonc @katy_beckermann @brian_rini ┈┈🔹#CME info 👉 bit.ly/3iLN6aX 👈 @BonumCe ┈┈🔸Support by edu grants from Eisai & @Merck 🔹#TumorBoardTuesday #OncTwitter twitter.com/i/broadcasts/1lDGL

  13. ⏰ Countdown to 8p ET has begun!
    ✅Answer #PreTest polls in the tweet below👇
    🕗 Tune in w #TumorBoardTues & @shilpaonc @katy_beckermann & @brian_rini
    🔁Retweet & tag colleagues🩺
    🏆 Claim your CME

    Simple as 🔢
    ---
    RT @TumorBoardTues
    1/🛎️#TumorBoardTuesday #OncTwitter #NephTwitter
    #RenalCell wk continues🔁

    🗓️Thu 12.15 @ 8p ET

    ⚙️Mnging AEs w TKI/IO combos

    #CME ℹ️🔗bit.ly/3iLN6aX
    Supported by edu grants from Eisai & @Merck
    🚨Be rea…
    twitter.com/TumorBoardTues/sta

  14. ⏰ Countdown to 8p ET has begun!
    ✅Answer #PreTest polls in the tweet below👇
    🕗 Tune in w #TumorBoardTues & @shilpaonc @katy_beckermann & @brian_rini
    🔁Retweet & tag colleagues🩺
    🏆 Claim your CME

    Simple as 🔢
    ---
    RT @TumorBoardTues
    1/🛎️#TumorBoardTuesday #OncTwitter #NephTwitter
    #RenalCell wk continues🔁

    🗓️Thu 12.15 @ 8p ET

    ⚙️Mnging AEs w TKI/IO combos

    #CME ℹ️🔗bit.ly/3iLN6aX
    Supported by edu grants from Eisai & @Merck
    🚨Be rea…
    twitter.com/TumorBoardTues/sta

  15. 6/ #TumorBoardTuesday #RenalCell #NephTwitter

    🟢#PreTest Q 4️⃣
    📊Pt treated w/ combo of cabo + nivo develops G3 HTN. Cabo therapy is held & pt receives anti-hypertensive medication & BP recovers to baseline. At what dose can cabozantinib be restarted?

  16. 6/ #TumorBoardTuesday #RenalCell #NephTwitter

    🟢#PreTest Q 4️⃣
    📊Pt treated w/ combo of cabo + nivo develops G3 HTN. Cabo therapy is held & pt receives anti-hypertensive medication & BP recovers to baseline. At what dose can cabozantinib be restarted?

  17. 5/ #TumorBoardTuesday #RenalCell #NephTwitter #MedTwitter #BonumCE

    #CME 🔗bit.ly/3FbuEQx

    🟢#PreTest Q 3️⃣
    📊 Pt treated w/ combo of pembro & lenvatinib for mRCC develops grade 3 diarrhea. How might you diagnose which drug is causing this toxicity?

  18. 4/ #TumorBoardTuesday #RenalCell #NephTwitter #MedTwitter #BonumCE

    #CME 🔗 bit.ly/3FbuEQx

    🟢#PreTest Q 2️⃣
    📊 Which of the following is NOT a characteristic of immune-mediated toxicities associated with the use of ICIs?

  19. 5/ #TumorBoardTuesday #RenalCell #NephTwitter #MedTwitter #BonumCE

    #CME 🔗bit.ly/3FbuEQx

    🟢#PreTest Q 3️⃣
    📊 Pt treated w/ combo of pembro & lenvatinib for mRCC develops grade 3 diarrhea. How might you diagnose which drug is causing this toxicity?

  20. 4/ #TumorBoardTuesday #RenalCell #NephTwitter #MedTwitter #BonumCE

    #CME 🔗 bit.ly/3FbuEQx

    🟢#PreTest Q 2️⃣
    📊 Which of the following is NOT a characteristic of immune-mediated toxicities associated with the use of ICIs?

  21. 3/ #TumorBoardTuesday #RenalCell #NephTwitter #MedTwitter #BonumCE

    #CME🔗bit.ly/3FbuEQx

    🟢#PreTest Q 1️⃣
    📊 Which of the following is a common high-grade toxicity associated with the use of TKIs in the management of metastatic RCC?

  22. 3/ #TumorBoardTuesday #RenalCell #NephTwitter #MedTwitter #BonumCE

    #CME🔗bit.ly/3FbuEQx

    🟢#PreTest Q 1️⃣
    📊 Which of the following is a common high-grade toxicity associated with the use of TKIs in the management of metastatic RCC?

  23. 1/🛎️#TumorBoardTuesday #OncTwitter #NephTwitter
    #RenalCell wk continues🔁

    🗓️Thu 12.15 @ 8p ET

    ⚙️Mnging AEs w TKI/IO combos

    #CME ℹ️🔗bit.ly/3iLN6aX
    Supported by edu grants from Eisai & @Merck
    🚨Be ready 4 tmrw!
    ✅Answer #PreTest polls👇
    🔁Retweet & tag colleagues🩺

  24. 1/🛎️#TumorBoardTuesday #OncTwitter #NephTwitter
    #RenalCell wk continues🔁

    🗓️Thu 12.15 @ 8p ET

    ⚙️Mnging AEs w TKI/IO combos

    #CME ℹ️🔗bit.ly/3iLN6aX
    Supported by edu grants from Eisai & @Merck
    🚨Be ready 4 tmrw!
    ✅Answer #PreTest polls👇
    🔁Retweet & tag colleagues🩺

  25. 📢We’re here on #TumorBoardTuesday!!

    🥼@shilpaonc teaches us about treating a relapse in #RenalCellCarcinoma

    👇🏽👇🏽

    📱Weigh in your answers
    🧾Bring receipts
    🙋Ask Q’s
    📊check polls
    🔁RT
    👩🏽‍⚕️tag peers
    @MPishvaian @JohnEbbenMDPhD
    #MedTwitter
    ---
    RT @shilpaonc
    @TumorBoardTues @MPishvaian 1/18 #TumorBoardTuesday #RenalCancer #OncTwitter

    60yo 👴🏽#RenalCell dx in 2022 tx with right radical nephrectomy
    6mo f/u
    Uses WC d/t DM2 - limited mobility …
    twitter.com/shilpaonc/status/1

  26. 📢We’re here on #TumorBoardTuesday!!

    🥼@shilpaonc teaches us about treating a relapse in #RenalCellCarcinoma

    👇🏽👇🏽

    📱Weigh in your answers
    🧾Bring receipts
    🙋Ask Q’s
    📊check polls
    🔁RT
    👩🏽‍⚕️tag peers
    @MPishvaian @JohnEbbenMDPhD
    #MedTwitter
    ---
    RT @shilpaonc
    @TumorBoardTues @MPishvaian 1/18 #TumorBoardTuesday #RenalCancer #OncTwitter

    60yo 👴🏽#RenalCell dx in 2022 tx with right radical nephrectomy
    6mo f/u
    Uses WC d/t DM2 - limited mobility …
    twitter.com/shilpaonc/status/1

  27. ❄️ 1 hour until TONIGHT'S #TumorBoardTuesday!!

    ❄️ @shilpaonc takes us through treating clear cell #RenalCellCarcinoma

    ❄️ Snag some hot chocolate (+Bailey’s 😉), grab a blanket, and prepare your 🧠 with these #CME👇🏽See you soon!

    ---
    RT @TumorBoardTues
    #TumorBoardTuesday #PreTest❓Free #CME🔗: integrityce.com/tbt

    🤔B4⃣ @shilpaonc🗣️management of #RenalCell🦀, test your🧠with these 2❓s:

    Q1⃣: What Tx would you choose for a PS=2 hom…
    twitter.com/TumorBoardTues/sta

  28. ❄️ 1 hour until TONIGHT'S #TumorBoardTuesday!!

    ❄️ @shilpaonc takes us through treating clear cell #RenalCellCarcinoma

    ❄️ Snag some hot chocolate (+Bailey’s 😉), grab a blanket, and prepare your 🧠 with these #CME👇🏽See you soon!

    ---
    RT @TumorBoardTues
    #TumorBoardTuesday #PreTest❓Free #CME🔗: integrityce.com/tbt

    🤔B4⃣ @shilpaonc🗣️management of #RenalCell🦀, test your🧠with these 2❓s:

    Q1⃣: What Tx would you choose for a PS=2 hom…
    twitter.com/TumorBoardTues/sta

  29. ❄️ 1 hour until TONIGHT'S #TumorBoardTuesday!!

    ❄️ @shilpaonc takes us through treating clear cell #RenalCellCarcinoma

    ❄️ Snag some hot chocolate (+Bailey’s 😉), grab a blanket, and prepare your 🧠 with these #CME👇🏽See you soon!

    ---
    RT @TumorBoardTues
    #TumorBoardTuesday #PreTest❓Free #CME🔗: integrityce.com/tbt

    🤔B4⃣ @shilpaonc🗣️management of #RenalCell🦀, test your🧠with these 2❓s:

    Q1⃣: What Tx would you choose for a PS=2 hom…
    twitter.com/TumorBoardTues/sta

  30. #TumorBoardTuesday #PreTest❓Free #CME🔗: integrityce.com/tbt

    🤔B4⃣ @shilpaonc🗣️management of #RenalCell🦀, test your🧠with these 2❓s:

    Q1⃣: What Tx would you choose for a PS=2 homebound Pt with Clear Cell #RCC & poor risk features - disease relapse (1st relapse)❓

  31. #TumorBoardTuesday #PreTest❓Free #CME🔗: integrityce.com/tbt

    🤔B4⃣ @shilpaonc🗣️management of #RenalCell🦀, test your🧠with these 2❓s:

    Q1⃣: What Tx would you choose for a PS=2 homebound Pt with Clear Cell #RCC & poor risk features - disease relapse (1st relapse)❓

  32. #TumorBoardTuesday #CME
    🔗integrityce.com/tbt

    👆🏽
    Important background info to assist making the treatment decisions.

    Patient is 75yo male with limited mobility & homebound
    Stage 2 #RenalCell
    Relapse within 6mos 🫁 mediastinum
    Risk is poor
    Karnofsky PS 70%
    @shilpaonc

  33. #TumorBoardTuesday #CME
    🔗integrityce.com/tbt

    👆🏽
    Important background info to assist making the treatment decisions.

    Patient is 75yo male with limited mobility & homebound
    Stage 2 #RenalCell
    Relapse within 6mos 🫁 mediastinum
    Risk is poor
    Karnofsky PS 70%
    @shilpaonc

  34. #TumorBoardTuesday #PreTest❓Free #CME🔗: integrityce.com/tbt

    🤔B4⃣ @shilpaonc🗣️management of advanced #RenalCell🦀, test your🧠with these 2❓s:

    Q1⃣: What Tx would you choose for a PS=2 Pt with Clear Cell RCC & poor risk features, whose disease has relapsed (1st relapse)❓

  35. #TumorBoardTuesday #PreTest❓Free #CME🔗: integrityce.com/tbt

    🤔B4⃣ @shilpaonc🗣️management of advanced #RenalCell🦀, test your🧠with these 2❓s:

    Q1⃣: What Tx would you choose for a PS=2 Pt with Clear Cell RCC & poor risk features, whose disease has relapsed (1st relapse)❓

  36. #TumorBoardTuesday #RenalCell @shilpaonc

    📅Tuesday, 12/13/22 at🕗8PM ET
    ✅polls
    ⚖️Weigh in
    🧾Bring citations
    🔁Retweet
    🏷️tag your 🩺 colleagues
    🏆Earn your 🆓 CME (AMA & MOC) integrityce.com/tbt

    Before the case:
    🧐Tell us where you are in your 🩺 journey
    👇🏽👇🏽👇🏽

  37. #TumorBoardTuesday #RenalCell @shilpaonc

    📅Tuesday, 12/13/22 at🕗8PM ET
    ✅polls
    ⚖️Weigh in
    🧾Bring citations
    🔁Retweet
    🏷️tag your 🩺 colleagues
    🏆Earn your 🆓 CME (AMA & MOC) integrityce.com/tbt

    Before the case:
    🧐Tell us where you are in your 🩺 journey
    👇🏽👇🏽👇🏽

  38. #TumorBoardTuesday #RenalCell @shilpaonc

    📅Tuesday, 12/13/22 at🕗8PM ET
    ✅polls
    ⚖️Weigh in
    🧾Bring citations
    🔁Retweet
    🏷️tag your 🩺 colleagues
    🏆Earn your 🆓 CME (AMA & MOC) integrityce.com/tbt

    Before the case:
    🧐Tell us where you are in your 🩺 journey
    👇🏽👇🏽👇🏽

  39. #TumorBoardTuesday #RenalCell @shilpaonc

    📅Tuesday, 12/13/22 at🕗8PM ET
    ✅polls
    ⚖️Weigh in
    🧾Bring citations
    🔁Retweet
    🏷️tag your 🩺 colleagues
    🏆Earn your 🆓 CME (AMA & MOC) integrityce.com/tbt

    Before the case:
    🧐Tell us where you are in your 🩺 journey
    👇🏽👇🏽👇🏽

  40. #TumorBoardTuesday #RenalCell

    👉Last night we learned that there has an💥of Tx options for Pts with advanced kidney Ca
    twitter.com/TumorBoardTues/sta

    📢Join #TumorBoardTuesday TONIGHT 12/13/22 at 8pm ET when @shilpaonca🗣️patient with relapsed Clear Cell RCC
    ✅Prepare your own Q’s NOW
    ---
    RT @TumorBoardTues
    2/ #TumorBoardTuesday #BonumCE #RenalCell #On
    twitter.com/TumorBoardTues/sta

  41. #TumorBoardTuesday #RenalCell

    👉Last night we learned that there has an💥of Tx options for Pts with advanced kidney Ca
    twitter.com/TumorBoardTues/sta

    📢Join #TumorBoardTuesday TONIGHT 12/13/22 at 8pm ET when @shilpaonca🗣️patient with relapsed Clear Cell RCC
    ✅Prepare your own Q’s NOW
    ---
    RT @TumorBoardTues
    2/ #TumorBoardTuesday #BonumCE #RenalCell #On
    twitter.com/TumorBoardTues/sta

  42. 27/#TumorBoardTuesday #BonumCE
    #OncTwitter #NephTwitter #MedTwitter

    🧗Climb your next RCC Mt⛰️
    w experts @brian_rini @shilpaonc @katy_beckermann

    Next🆙
    Tue, 12/13: Convo w @shilpaonc

    Then on🗓Thu, Dec 15 @ 8pm ET/5pm PT
    🔥#RenalCell Carcinoma Fireside Chat🎥🔥

  43. 27/#TumorBoardTuesday #BonumCE
    #OncTwitter #NephTwitter #MedTwitter

    🧗Climb your next RCC Mt⛰️
    w experts @brian_rini @shilpaonc @katy_beckermann

    Next🆙
    Tue, 12/13: Convo w @shilpaonc

    Then on🗓Thu, Dec 15 @ 8pm ET/5pm PT
    🔥#RenalCell Carcinoma Fireside Chat🎥🔥

  44. 26/#TumorBoardTuesday #BonumCE #RenalCell

    🔴Post Poll4️⃣
    #CME➡️ bit.ly/3W0R1Pq

    Pt w mRCC
    🔸Initiated tx w pembro + lenva
    🔹Developed G3 diarrhea
    🔸Lenva withheld & anti-diarrheal treatment initiated 🔹Diarrhea now resolved.

    🔴What next step is best for the pt?

  45. 26/#TumorBoardTuesday #BonumCE #RenalCell

    🔴Post Poll4️⃣
    #CME➡️ bit.ly/3W0R1Pq

    Pt w mRCC
    🔸Initiated tx w pembro + lenva
    🔹Developed G3 diarrhea
    🔸Lenva withheld & anti-diarrheal treatment initiated 🔹Diarrhea now resolved.

    🔴What next step is best for the pt?

  46. 25/#TumorBoardTuesday #BonumCE #RenalCell
    #OncTwitter #NephTwitter #MedTwitter

    🔴Post Poll3️⃣
    CME➡️ bit.ly/3W0R1Pq

    🔴Which of the following is an AE that is commonly observed with both ICIs and TKIs?

  47. 25/#TumorBoardTuesday #BonumCE #RenalCell
    #OncTwitter #NephTwitter #MedTwitter

    🔴Post Poll3️⃣
    CME➡️ bit.ly/3W0R1Pq

    🔴Which of the following is an AE that is commonly observed with both ICIs and TKIs?

  48. 27/#TumorBoardTuesday #BonumCE
    #OncTwitter #NephTwitter #MedTwitter

    🧗Climb your next RCC Mt⛰️
    w experts @brian_rini @shilpaonc @katy_beckermann

    Next🆙
    Tue, 12/13: Convo w/ @shilpaonc

    Then on
    🗓Thu, Dec 15 @ 8pm ET/5pm PT
    🔥#RenalCell Carcinoma Fireside Chat🎥🔥